With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But ...

The "most obvious culprit" behind the company's "dramatic change in fortunes" is the rise of Ozempic and similar drugs, which ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

At its peak, WeightWatchers was seen as being synonymous with safe and controlled weight loss. With 4.5million subscribers ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

Every plus-sized woman I knew as a teenager would attend WeightWatchers in phases; they’d go, lose weight, leave, put the ...

WeightWatchers, officially rebranded as WW International ( NASDAQ: WW ), has blamed its financial woes on the GLP-1 drug wave ...

It changed the way we diet, but now Weight Watchers’ fortunes seem to be fading. Katie Rosseinsky explores how the Ozempic ...